STOCK COMPENSATION (Details Narrative) - USD ($)	12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Apr. 20, 2020	Mar. 31, 2020	Dec. 31, 2019
Common stock, shares issued	38,730,150	35,231,776		630,500	606,395
Common stock, shares authorized	600,000,000	600,000,000
Stock Bonus Plans [Member]
Common stock, shares issued	345,096
Common stock, shares authorized	783,760
Incentive Stock Bonus Plan [Member]
Common stock, shares authorized	640,000
Issuance of restricted stock	$ 300,000	$ 0.3
Unrecognized compensation expense	$ 400,000
Weighted average period	1 year 2 months 12 days
Incentive Stock Option Plans [Member]
Common stock, shares authorized	138,400
Non-Qualified Stock Options Plans [Member]
Common stock, shares authorized	9,987,200
Unrecognized compensation expense	$ 2,100,000
Remaining compensation expense	$ 5,800,000
Issuance of common stock options purchase shares	3,600,000
Performance based stock options shares granted			1,872,000
Stock price	$ 10.93
Stock options vest description	the following performance goals: i) 25% of the options will vest when the closing price of the Company’s common stock exceeds $20.00 for ten consecutive trading days; ii) 50% of the options will vest when the closing price of the Company’s common stock exceeds $25.00 for ten consecutive trading days; iii) 75% of the options will vest when the closing price of the Company’s common stock exceeds $30.00 for ten consecutive trading days; and iv) 100% of the options will vest when either (a) the filing of the first marketing application for any pharmaceutical based upon the Company’s Multikine technology, in the US, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia or (b) the closing price of the Company’s common stock exceeds $40.00 for ten consecutive trading days.
Fair value per share	$ 4.21
Grant date fair value remaining outstanding	$ 7,881,120
Grant date fair value remaining		$ 8.6
Implicit life of options	1 year 8 months 12 days
Expense life over next	1 year 3 months
Stock Compensation Plans [Member]
Common stock, shares issued	150,695	150,695
Common stock, shares authorized	634,000